liver cancer

Researchers report that epigenetic editing can silence and eliminate the hepatitis B virus, which infects hundreds of millions of people chronically and is a leading cause of liver cancer. Unlike traditional antivirals, the approach targets the virus's genetic controls rather than directly cutting its DNA, potentially offering a functional cure. The finding is drawing significant attention in scientific circles, with discussion focused on whether the technique can be translated safely and effectively into human therapies.